Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779467 · ClinicalTrials.gov registry record · Phase 1
Epidural Neostigmine for Labor Pain
A Phase 1 study of Labor Pain, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00779467: Completed Phase 1 study of Labor Pain, sponsored by Wake Forest University.
NCT00779467 is a Phase 1 study of Labor Pain that has completed, run by Wake Forest University. The registered enrollment target is 200 participants, roughly in line with the 190-participant average among 14 other Labor Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779467, a Phase 1 study of Labor Pain, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see which dose of epidural neostigmine is the best additive to use with the numbing medication used in an epidural during labor.
Primary Outcome
Median hourly total bupivacaine consumption. Drug amount consumed per hour of each group (arm)
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Neostigmine
- DRUG fentanyl
Study Locations (1)
North Carolina
- Forsyth Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
What the finished NCT00779467 record still lists
NCT00779467 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 190-participant average among 14 other Labor Pain trials with a reported enrollment target.
The record links to 1 condition, with Labor Pain appearing as the primary indexed condition, and to 3 interventions - of which Bupivacaine is the first listed.
NCT00779467 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00779467 about?
NCT00779467 is a clinical study titled "Epidural Neostigmine for Labor Pain". The purpose of this study is to see which dose of epidural neostigmine is the best additive to use with the numbing medication used in an epidural during labor.
What is the current status of trial NCT00779467?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2008-10. Estimated completion is 2013-11.
What conditions does trial NCT00779467 study?
This clinical trial studies the following conditions: Labor Pain.
What interventions are being tested in trial NCT00779467?
The interventions under investigation include: Bupivacaine (DRUG), Neostigmine (DRUG), fentanyl (DRUG).
Who is sponsoring clinical trial NCT00779467?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00779467 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00779467's enrollment target sits among peer trials
200 4th of 14 higher than 11 of 14 other Labor Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Labor Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Stimulation To Induce Mothers Study
RECRUITING · Phase 4
-
ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL
RECRUITING · Phase 4
-
Intracervical Balloon Placement With Nitrous Oxide Administration
RECRUITING · Phase 3
-
CSE v. Epidural for Postpartum Depression
COMPLETED · NA
-
Virtual Reality Compared to Nitrous Oxide for Labor Analgesia
COMPLETED · NA
-
Comparison of PIEB vs CEI for Labor Analgesia
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia